Creatine is widely known as a performance supplement in sport, but growing research suggests it may also support brain energy, cognitive performance, and mental fatigue.
For individuals with ADHD, where attention, executive function, and cognitive stamina are often challenged, creatine is increasingly being explored as a potential adjunct to optimise cognitive function.
While not a treatment for ADHD itself, creatine may have a role in supporting brain function under load, particularly in selected individuals.
How Creatine Supports Brain Function
Creatine plays a key role in cellular energy production through the phosphocreatine (PCr) system, helping regenerate ATP, the brain’s primary energy source.
This matters because:
- The brain accounts for roughly 20% of resting energy expenditure despite comprising only 2% of body mass
- Executive function (attention, working memory, response inhibition) is especially energy-dependent
- The PCr system acts as a rapid energy buffer during cognitively demanding tasks, maintaining performance when metabolic demand is high
- Even mild disruption to this buffer can impair focus, processing speed, and cognitive stamina
Supplementation has been shown to increase brain creatine stores, providing a biological basis for cognitive effects (Candow et al., 2023). Creatine also has antioxidant and anti-inflammatory properties, supporting neuroprotection and mitochondrial stability.
The Biological Case for Creatine in ADHD
The rationale for creatine in ADHD is more specific than general cognitive enhancement. It centres on prefrontal energetics.
ADHD involves dysregulation of the prefrontal cortex and its connections to the striatum, circuits that govern attention, impulse control, and response consistency. These circuits have exceptionally high metabolic demands. There is a well-supported hypothesis that ADHD involves dysfunction in neuronal and glial energy metabolism in these frontostriatal networks, and neuroimaging studies using magnetic resonance spectroscopy (MRS) have identified altered bioenergetic markers, including creatine-related metabolites, in the prefrontal regions of individuals with ADHD.
Perhaps the most compelling biological evidence comes from cerebral creatine deficiency syndromes (CCDS): rare genetic conditions that impair the body’s ability to synthesise, convert, or transport creatine into the brain. These conditions produce a neurodevelopmental phenotype that includes intellectual disability, language delay, and prominently, hyperactivity and attentional difficulties, an ADHD-like picture. In the forms where oral creatine supplementation can reach the brain, treatment produces partial or significant reversal of these neurodevelopmental features (Candow et al., 2023).
This provides proof-of-concept that brain creatine status is causally linked to neurodevelopmental outcomes, including ADHD-like phenotypes. It does not mean ADHD is a creatine deficiency disorder, but it does ground the hypothesis in established biology.
What Does the Evidence Say? (2024-2026 Update)
No direct ADHD trials exist
A 2025 review on creatine in psychiatric and neurodevelopmental conditions found no published RCTs evaluating creatine supplementation specifically for ADHD, in children or adults (Han et al., 2025). The review identified ADHD as one of the most significant research gaps in this field, calling for rigorous trials with adequate sample sizes, appropriate controls, and neuroimaging outcomes.
Indirect cognitive evidence in adults
A 2024 systematic review and meta-analysis of 16 RCTs (n = 492; ages 20.8-76.4 years) found that creatine supplementation produced significant positive effects on (Xu et al., 2024):
- Memory performance
- Attention time (faster responses on timed attention tasks)
- Information processing speed time (faster reaction times on timed tasks)
However:
- Attention scores and processing speed scores themselves showed no significant improvement
- Effects on overall cognition and executive function were non-significant
- Certainty of evidence ranged from moderate (memory) to low or very low for other domains
- Benefits were more apparent in individuals with existing health conditions, those aged 18-60, and in females
A separate 2023 meta-analysis focusing specifically on memory in healthy individuals reached broadly consistent conclusions (Prokopidis et al., 2023).
It is important to note that EFSA (EFSA, 2024) and the UK Nutrient Health Claims Committee (NHCC, 2024) have both independently reviewed the evidence base and concluded that a cause-and-effect relationship between creatine supplementation and cognitive improvement has not been established. Both regulatory bodies cited small sample sizes, heterogeneous outcome measures, and methodological limitations in the available trials. EFSA also raised specific concerns about the meta-analytic approach in the primary 2024 review, noting that pooling non-independent cognitive tests from the same studies inflates sample size estimates. These opinions relate primarily to low-dose supplementation (at or below 3 g/day) in healthy populations. They do not preclude efficacy at higher doses in specific clinical populations, but they appropriately set a high bar for any claims made.
Cognitive effects under sleep deprivation
A crossover study showed that creatine supplementation (20 g/day for 7 days) attenuated cognitive decline resulting from 36 hours of sleep deprivation, specifically on executive function tasks (Gordji-Nejad et al., 2024). Sleep disruption is extremely common in ADHD and is known to amplify cognitive deficits, making this finding particularly relevant to the population, even though it was conducted in healthy adults.
Evidence in children and adolescents
Direct evidence in paediatric populations is sparse. Studies of creatine supplementation in healthy children suggest that standard doses of 3-5 g/day may not produce meaningful increases in brain phosphocreatine levels in younger people. Dose-finding work in adolescents with depression suggests doses of at least 4 g/day sustained over several months, or higher short-term loading doses, are likely needed to achieve measurable brain bioenergetic effects in this age group. This is an important consideration for any paediatric application (Han et al., 2025).
The strongest paediatric brain evidence comes from a clinical trial in children with traumatic brain injury, where creatine supplementation over six months produced improvements in cognitive function, behaviour, and disability outcomes with good tolerability. While this population is not ADHD, it demonstrates that creatine can penetrate the developing brain, raise PCr levels, and produce neurobehavioural benefit in children (Candow et al., 2023).
A 2026 systematic review of creatine and cognition in older adults found positive associations with memory and attention, though the authors noted the evidence base remains sparse, with only six studies of predominantly moderate to poor methodological quality (Marshall et al., 2026).
Bottom line: Creatine shows signal, not certainty, a view reflected even in critical appraisals of the field (Eckert, 2025). The signal is biologically plausible and supported by indirect clinical evidence. But the evidence base has real limitations, no direct ADHD trials exist, and regulatory bodies have not substantiated cognitive health claims.
Why This May Be Relevant for ADHD
ADHD is not simply a disorder of attention. It often involves:
- Reduced cognitive endurance
- Increased mental fatigue
- Difficulty sustaining effort over time
- Response variability, with inconsistent performance that worsens under cognitive load
These are precisely the features linked to prefrontal energetic dysregulation, and the areas where creatine’s mechanism is most relevant.
In practice, creatine may be most worth considering for individuals with ADHD who:
- Experience cognitive fatigue or “brain fog” as a prominent feature
- Have suboptimal sleep (extremely common in ADHD, and a context where creatine has direct supporting evidence)
- Are under high academic or occupational cognitive demand
- Follow low-meat or vegetarian diets (lower baseline creatine stores)
- Show a partial response to stimulant medication, where fatigue or cognitive stamina remains a limiting factor despite adequate dose
Practical Use: Dosing and Safety
Dosing
The standard supplementation dose of 3-5 g/day is well-established for muscle and general health purposes. However, current evidence suggests this dose range may not be sufficient to meaningfully raise brain phosphocreatine levels, particularly in children and adolescents (Han et al., 2025). Studies achieving measurable brain effects have generally used higher doses (at least 4 g/day sustained over months, or short-term loading at higher amounts). The optimal dose for cognitive benefit in ADHD, if creatine proves effective, is not yet established.
For adults exploring creatine as a cognitive support strategy, 3-5 g/day of creatine monohydrate remains a reasonable and well-tolerated starting point, with the understanding that brain effects, if present, may require sustained use over weeks to months.
Form: Creatine monohydrate (most studied and reliable)
Timing: Flexible; consistency matters more than timing
Safety
Creatine monohydrate has a well-established safety record across a range of clinical populations, including children. Studies in paediatric neuromuscular conditions, traumatic brain injury, and rare creatine deficiency disorders have found no significant adverse events, organ toxicity, or growth concerns (Candow et al., 2023). In adults and children alike:
- Generally well tolerated
- Maintain good hydration
- Use caution in those with renal impairment
- Mild gastrointestinal symptoms and temporary weight gain (water retention) can occur at higher doses, and are generally dose-dependent and transient
Where Creatine Fits in ADHD Care
Creatine is best viewed as a supportive, investigational adjunct, not a primary treatment, and not yet a validated one.
It does not replace:
- Comprehensive ADHD assessment
- Evidence-based medication (when indicated)
- Psychological, educational, and behavioural supports
Instead, it may complement foundational interventions such as sleep optimisation, nutrition, and physical activity. For carefully selected individuals, it may offer incremental improvements in cognitive stamina and resilience, but this remains to be confirmed in direct trials.
Any consideration of creatine supplementation in a clinical context, particularly in children, should involve discussion with the treating clinician, appropriate monitoring, and realistic expectations.
A Balanced, Practical Take
Creatine sits in an interesting space:
- Biologically plausible, with a specific and coherent mechanism in ADHD-relevant brain circuits
- Supported by a proof-of-concept model in creatine deficiency syndromes
- Increasingly studied, with modest but real cognitive signals in adult meta-analyses
- An excellent safety profile, including in children
- Safe, accessible, and inexpensive
But:
- No direct ADHD trials exist, and this is the central limitation
- Evidence is heterogeneous and methodologically limited
- Regulatory bodies have not substantiated cognitive health claims
- Standard doses may be insufficient for brain effects, particularly in younger people
- Effects are likely modest and context-dependent
For carefully selected patients, it represents a reasonable adjunct worth considering, particularly where fatigue, sleep disruption, and cognitive load are prominent features. Formal trial evidence is needed before creatine can be considered anything beyond investigational in this context.
As always, supplements should be used thoughtfully, within a broader evidence-based ADHD care plan, and never as a substitute for it.
References
- Candow, D.G. et al. (2023). “Heads Up” for creatine supplementation and its potential applications for brain health and function. Sports Medicine. https://link.springer.com/article/10.1007/s40279-023-01870-9
- Eckert, I. (2025). Creatine supplementation for cognition: a critical perspective on promise, proof, and public perception. Journal of Nutrition, 155(10), 3143-3147. https://pubmed.ncbi.nlm.nih.gov/40744234/
- European Food Safety Authority Panel on Nutrition, Novel Foods and Food Allergens (2024). Creatine and improvement in cognitive function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 22(11), e9100. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2024.9100
- Gordji-Nejad, A. et al. (2024). Single dose creatine improves cognitive performance and induces changes in cerebral high energy phosphates during sleep deprivation. Scientific Reports. https://www.nature.com/articles/s41598-024-54249-9
- Han, E.S., Yancey, J.R., Yurgelun-Todd, D.A., Kondo, D.G., Boxer, D.J. and Renshaw, P.F. (2025). The role of brain creatine in behavioral health conditions. Frontiers in Psychiatry, 16, 1667639. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1667639/full
- Marshall, S. et al. (2026). Creatine and cognition in aging: a systematic review of evidence in older adults. Nutrition Reviews, 84(2), 333-344. https://academic.oup.com/nutritionreviews/article/84/2/333/8253584
- UK Nutrient Health Claims Committee (2024). Scientific opinion: creatine supplementation and improved cognitive function. https://www.gov.uk/government/publications/uknhcc-scientific-opinion-creatine-supplementation-and-improved-cognitive-function
- Prokopidis, K. et al. (2023). Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomised controlled trials. Nutrition Reviews, 81(4), 416-427. https://academic.oup.com/nutritionreviews/article/81/4/416/6671817
- Xu, C., Bi, S., Zhang, W. and Luo, L. (2024). The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition, 11, 1424972. (Corrigendum: Frontiers in Nutrition, 2025, 12, 1570800) https://pubmed.ncbi.nlm.nih.gov/39070254/
If you’re struggling to source medication or need help adjusting a plan, please reach out. At Pandion Health, our team of experienced psychiatrists, behavioural paediatricians, psychologists, therapists, and ADHD coaches are here to support you.